Business
Accuray and the University of Wisconsin-Madison Announce Master Research Agreement to Improve Personalized Care for Patients with Cancer
Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar™ adaptive radiation therapy platform. This agreement builds on longstanding shared history of partnership between Accuray and the school to develop precision radiation therapy technologies using imaging to precisely deliver dose sculpting for cancer treatments. This newe
About this update from Accuray Incorporated
[{"type":"text","content":"MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar™ adaptive radiation therapy platform. This agreement builds on longstanding shared history of partnership between Accuray and the school to develop precision radiation therapy technologies using imaging to precisely deliver dose sculpting for cancer treatments. This newest collaboration will support clinical research, education and training, and the development of adaptive therapies that help empower medical care teams to continually raise the standard in cancer care.","length":754,"tagName":"p"},{"type":"image","alt":"University of Wisconsin School of Medicine and Public Health","displaySize":"","headline":null,"caption":"University of Wisconsin School of Medicine and Public Health","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":102,"url":"https://media.zenfs.com/en/prnewswire.com/8132e0548ca66d7f28cf4c2875706ccf"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/O2iRJjDpgkxLufltce2n7g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE4MA--/https://media.zenfs.com/en/prnewswire.com/8132e0548ca66d7f28cf4c2875706ccf","width":400,"height":102},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/RJi2TfF_PhOjZL3L1XC7xA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTE2Mw--/https://media.zenfs.com/en/prnewswire.com/8132e0548ca66d7f28cf4c2875706ccf","width":400,"height":102}},"href":"https://mma.prnewswire.com/media/2981238/SCHOMEDIPU_Accuray.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""Our success depends on collaboration, innovation, and the energy that comes from addressing meaningful clinical needs for patients," said Steve La Neve, President and CEO of Accuray. "This Master Research Agreement formalizes and expands our longstanding relationship with the University of Wisconsin–Madison and grounds our innovations in real-world clinical practice and impactful patient care. By leveraging our respective strengths, we aim to extend the curative power of radiotherapy so departments of all sizes around the world can benefit from advanced adaptive therapies."","length":606,"tagName":"p"},{"type...